Low incidence and morbidity of Epstein-Barr virus reactivation following donor lymphocyte infusions.
作者信息
Martinovic Danilo, Hasenkamp Justin, Jung Wolfram, Tucholski Frank, Maas Jens-Holger, Wulf Gerald Georg
机构信息
Haematology and Medical Oncology University Medicine Göttingen Göttingen Germany.
Transfusion Medicine University Medicine Göttingen Göttingen Germany.
出版信息
EJHaem. 2023 Mar 13;4(2):563-565. doi: 10.1002/jha2.672. eCollection 2023 May.
Abstract
摘要
相似文献
1
Low incidence and morbidity of Epstein-Barr virus reactivation following donor lymphocyte infusions.供体淋巴细胞输注后爱泼斯坦-巴尔病毒再激活的低发生率和低发病率。
EJHaem. 2023 Mar 13;4(2):563-565. doi: 10.1002/jha2.672. eCollection 2023 May.
2
Non-uniform Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease.移植后淋巴组织增生性疾病患者接受供者淋巴细胞输注后，EB 病毒特异性 T 细胞呈非均一性扩增。
Front Immunol. 2019 Oct 29;10:2489. doi: 10.3389/fimmu.2019.02489. eCollection 2019.
3
Epstein-Barr Virus-Related Post-Transplantation Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后与 EBV 相关的移植后淋巴增殖性疾病。
Biol Blood Marrow Transplant. 2018 Jul;24(7):1341-1349. doi: 10.1016/j.bbmt.2018.02.026. Epub 2018 Mar 9.
4
Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.异基因干细胞移植后高危患者通过分子监测和抢先使用利妥昔单抗预防爱泼斯坦-巴尔病毒淋巴增殖性疾病
Blood. 2002 Jun 15;99(12):4364-9. doi: 10.1182/blood.v99.12.4364.
5
Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植中与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增殖性疾病预防策略
Rev Med Virol. 2020 Jul;30(4):e2108. doi: 10.1002/rmv.2108. Epub 2020 Apr 17.
6
Epstein-Barr virus-associated leukemic lymphoma after allogeneic stem cell transplantation.异基因造血干细胞移植后 Epstein-Barr 病毒相关白血病淋巴瘤
J Clin Virol. 2016 Jul;80:82-6. doi: 10.1016/j.jcv.2016.04.020. Epub 2016 May 6.
7
Programmed death 1 monoclonal antibody helped to treat mixed chimeric and reactivation of Epstein-Barr virus in a patient with adult-onset chronic active Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation: A case report.程序性死亡 1 单克隆抗体有助于治疗异基因造血干细胞移植后成人慢性活动性 EBV 感染患者的混合嵌合和 EBV 再激活：一例报告。
Medicine (Baltimore). 2022 Jan 14;101(2):e28542. doi: 10.1097/MD.0000000000028542.
8
9
Pre-emptive rituximab for Epstein-Barr virus reactivation after haplo-hematopoietic stem cell transplantation.单倍体造血干细胞移植后用于预防爱泼斯坦-巴尔病毒激活的利妥昔单抗
Pediatr Int. 2017 Sep;59(9):973-978. doi: 10.1111/ped.13336.
10
Incidence, risk factors, and clinical significance of Epstein-Barr virus reactivation in myelodysplastic syndrome after allogeneic haematopoietic stem cell transplantation.异基因造血干细胞移植后骨髓增生异常综合征中 EBV 再激活的发生率、危险因素及临床意义。
Ann Hematol. 2019 Apr;98(4):987-996. doi: 10.1007/s00277-019-03603-3. Epub 2019 Feb 4.
引用本文的文献
1
Reduced-dose donor lymphocyte infusion is a viable therapeutic strategy for Epstein-Barr virus-related post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation: a single-center experience.低剂量供体淋巴细胞输注是造血干细胞移植后爱泼斯坦-巴尔病毒相关移植后淋巴增殖性疾病的一种可行治疗策略：单中心经验
Clin Exp Med. 2025 May 12;25(1):152. doi: 10.1007/s10238-025-01685-0.
本文引用的文献
1
Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study).输血相关 Epstein-Barr 病毒（EBV）感染：造血干细胞移植患儿的多中心前瞻性队列研究（TREASuRE 研究）。
Transfusion. 2021 Jan;61(1):144-158. doi: 10.1111/trf.16149. Epub 2020 Oct 22.
2
Non-uniform Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease.移植后淋巴组织增生性疾病患者接受供者淋巴细胞输注后，EB 病毒特异性 T 细胞呈非均一性扩增。
Front Immunol. 2019 Oct 29;10:2489. doi: 10.3389/fimmu.2019.02489. eCollection 2019.
3
Transfusion-related Epstein-Barr virus infection among stem cell transplant recipients: a retrospective cohort study in children.干细胞移植受者与输血相关的 EBV 感染：儿童回顾性队列研究。
Transfusion. 2012 Dec;52(12):2653-63. doi: 10.1111/j.1537-2995.2012.03611.x. Epub 2012 Mar 15.
4
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后，采用未经选择或 EBV 特异性 T 细胞进行活检证实的 EBV+淋巴瘤的过继免疫治疗。
Blood. 2012 Mar 15;119(11):2644-56. doi: 10.1182/blood-2011-08-371971. Epub 2011 Dec 2.
5
Transfusion-related infectious mononucleosis.输血相关性传染性单核细胞增多症
Scand J Infect Dis. 2002;34(10):777-8. doi: 10.1080/00365540260348626.
6
Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.异基因骨髓移植受者中爱泼斯坦-巴尔病毒相关淋巴增殖性疾病的生物学特性及过继性细胞治疗
Immunol Rev. 1997 Jun;157:195-216. doi: 10.1111/j.1600-065x.1997.tb00983.x.
7
8
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.输注供体白细胞以治疗异基因骨髓移植后与爱泼斯坦-巴尔病毒相关的淋巴增殖性疾病。
N Engl J Med. 1994 Apr 28;330(17):1185-91. doi: 10.1056/NEJM199404283301703.
Zotero 插件